Cite
HARVARD Citation
Zubair, A. et al. (2022). Brentuximab-Induced Sensorimotor Polyneuropathy With Acquired Demyelinating Features Resembling Chronic Inflammatory Demyelinating Polyneuropathy. Journal of clinical neuromuscular disease. 23 (3), p. . [Online].